Latest Insider Transactions at Royalty Pharma PLC (RPRX)
This section provides a real-time view of insider transactions for Royalty Pharma PLC (RPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Royalty Pharma plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Royalty Pharma plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2022
|
Gg 1978 Sicaf Sif S.A. Gg Strategic |
SELL
Open market or private sale
|
Indirect |
250,000
-1.09%
|
$10,500,000
$42.53 P/Share
|
|
Sep 07
2022
|
Mario Germano Giuliani |
SELL
Open market or private sale
|
Indirect |
261,881
-2.89%
|
$10,999,002
$42.66 P/Share
|
|
Aug 25
2022
|
Gg 1978 Sicaf Sif S.A. Gg Strategic |
SELL
Open market or private sale
|
Indirect |
1,994
-0.01%
|
$87,736
$44.0 P/Share
|
|
Aug 25
2022
|
Mario Germano Giuliani |
SELL
Open market or private sale
|
Indirect |
500
-0.01%
|
$22,000
$44.0 P/Share
|
|
Aug 10
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
8,995
-4.28%
|
$386,785
$43.93 P/Share
|
|
Aug 09
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
45,000
-10.67%
|
$1,935,000
$43.73 P/Share
|
|
Aug 09
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
11,859
-5.34%
|
$509,937
$43.92 P/Share
|
|
Aug 01
2022
|
Terrance P. Coyne EVP & CFO |
SELL
Open market or private sale
|
Indirect |
30,000
-3.0%
|
$1,290,000
$43.19 P/Share
|
|
Jul 28
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
4,046
-1.79%
|
$173,978
$43.97 P/Share
|
|
Jul 27
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
25,100
-3.11%
|
$1,079,300
$43.83 P/Share
|
|
Jul 26
2022
|
Marshall Urist EVP, Research & Investments |
SELL
Open market or private sale
|
Direct |
19,734
-100.0%
|
$848,562
$43.2 P/Share
|
|
Jul 26
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
19,329
-3.56%
|
$831,147
$43.07 P/Share
|
|
Jul 25
2022
|
Marshall Urist EVP, Research & Investments |
SELL
Open market or private sale
|
Direct |
3,600
-15.43%
|
$154,800
$43.05 P/Share
|
|
Jul 25
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
30,671
-4.59%
|
$1,288,182
$42.94 P/Share
|
|
Jul 08
2022
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,346
+21.29%
|
-
|
|
Jun 30
2022
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
903
+3.34%
|
$37,023
$41.52 P/Share
|
|
Jun 30
2022
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
903
+2.75%
|
$37,023
$41.52 P/Share
|
|
Jun 29
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
30,000
-6.64%
|
$1,260,000
$42.17 P/Share
|
|
Jun 24
2022
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,328
+20.05%
|
-
|
|
Jun 24
2022
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,328
+50.0%
|
-
|
|
Jun 24
2022
|
Errol B Desouza Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,328
+10.04%
|
-
|
|
Jun 24
2022
|
Ted W Love Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,328
+17.81%
|
-
|
|
Jun 24
2022
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,328
+16.94%
|
-
|
|
Jun 24
2022
|
Catherine M. Engelbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,328
+19.9%
|
-
|
|
Jun 24
2022
|
Gregory Norden Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,328
+10.04%
|
-
|
|
Jun 24
2022
|
Marshall Urist EVP, Research & Investments |
SELL
Open market or private sale
|
Direct |
23,333
-50.0%
|
$1,003,319
$43.19 P/Share
|
|
Jun 08
2022
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-9.8%
|
$4,100,000
$41.56 P/Share
|
|
May 27
2022
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
75,000
-6.84%
|
$3,075,000
$41.08 P/Share
|
|
May 27
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
13,974
-3.15%
|
$558,960
$40.77 P/Share
|
|
May 26
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
86,026
-16.23%
|
$3,441,040
$40.21 P/Share
|
|
May 23
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
100,000
-15.87%
|
$4,000,000
$40.27 P/Share
|
|
May 20
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
123,696
-21.5%
|
$4,824,144
$39.28 P/Share
|
|
May 19
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
26,304
-4.37%
|
$1,052,160
$40.09 P/Share
|
|
May 19
2022
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
75,000
-6.41%
|
$3,000,000
$40.44 P/Share
|
|
May 16
2022
|
Marshall Urist EVP, Research & Investments |
SELL
Open market or private sale
|
Direct |
23,333
-33.33%
|
$909,987
$39.85 P/Share
|
|
May 11
2022
|
Marshall Urist EVP, Research & Investments |
BUY
Conversion of derivative security
|
Direct |
70,000
+50.0%
|
-
|
|
Apr 14
2022
|
Legorreta Pablo G. CEO, Chairman of the Board |
SELL
Other acquisition or disposition
|
Direct |
350,000
-84.58%
|
-
|
|
Apr 14
2022
|
Legorreta Pablo G. CEO, Chairman of the Board |
SELL
Other acquisition or disposition
|
Indirect |
462,031
-100.0%
|
-
|
|
Mar 31
2022
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
964
+3.76%
|
$36,632
$38.87 P/Share
|
|
Mar 31
2022
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
964
+4.85%
|
$36,632
$38.87 P/Share
|
|
Mar 29
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
60,000
-9.07%
|
$2,280,000
$38.59 P/Share
|
|
Mar 21
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
39,867
-100.0%
|
$1,554,813
$39.05 P/Share
|
|
Mar 18
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
129,222
-56.37%
|
$5,039,658
$39.51 P/Share
|
|
Mar 17
2022
|
Rory B Riggs Director |
SELL
Other acquisition or disposition
|
Indirect |
1,836,488
-83.8%
|
-
|
|
Mar 17
2022
|
Rory B Riggs Director |
BUY
Other acquisition or disposition
|
Direct |
68,964
+4.82%
|
-
|
|
Feb 24
2022
|
Henry A Fernandez Director |
BUY
Open market or private purchase
|
Indirect |
32,500
+35.83%
|
$1,202,500
$37.49 P/Share
|
|
Dec 31
2021
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
958
+3.88%
|
$37,362
$39.11 P/Share
|
|
Dec 31
2021
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
958
+5.07%
|
$37,362
$39.11 P/Share
|
|
Dec 29
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
75,000
-11.23%
|
$3,000,000
$40.0 P/Share
|
|
Dec 28
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
109,448
-6.97%
|
$4,377,920
$40.21 P/Share
|